Pharmaceutical industry wants FDA to extend deadline for testing novel nitrosamines
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesNorth AmericaOTCPharmaceuticalsRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesNorth AmericaOTCPharmaceuticals